Vasomotor symptoms (VMS) and endothelial function: A randomised placebo-controlled trial of oral micronised Progesterone (Prometrium ®)

Centre for Menstrual Cycle and Ovulation Research (CeMCOR) (Canada)0 个研究点目标入组 165 人开始时间: 2005年5月10日最近更新: 2015年1月13日

适应症

试验速览

暂无简介。

•Women past menopause who are between one and ten years of their last menstrual period, not on any hormones for at least the past 6 months, experiencing hot flushes or night sweats and without any history or risk factors of heart disease (smoking, overweight, high lipid levels).

•Amendment to protocol as of 17/05/2006:
•1. Any menstruation in the preceding year
•2. History of hysterectomy without ovariectomy unless she is 60 years of age
•3. Use of ovarian hormone therapy (estrogen, progestin, progesterone or androgen) in the preceding six months
•4. Any risk factors for heart disease like smoker, high blood pressure, high cholesterol, diabetes, overweight, and history of angina or abnormal electrocardiogram (ECG)

发起方

Centre for Menstrual Cycle and Ovulation Research (CeMCOR) (Canada)